36 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... Mycobacterium tuberculosis ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... IDSA #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... Mycobacterium tuberculosis ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... IDSA #management #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Women with in HIV-AIDS ... (Pap test and HPV ... Episode of HPV ... #Treatment #management ... #HIVAIDS #pharmacology
Radiographic appearances of pulmonary diseases in HIV/AIDS Patients
 • Diffuse Interstitial Infiltrates: Pneumocystis jirovecii, M.tuberculosis, Histoplasma
appearances of pulmonary ... diseases in HIV ... /AIDS Patients ... edema; ARDS, Metastatic ... Infectious Diseases
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... in HIV-AIDS Preventing ... to 5 mg/kg/day IV ... #Treatment #management ... #HIVAIDS #pharmacology
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
Pulmonary Infections ... in HIV-AIDS Bacterial ... CD4 < 200: CMV, HSV ... • CD4 < 200: Pulmonary ... ID_fellows #Pulmonary
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... Bacterial Enteric Infections ... in HIV-AIDS Preventing ... #Treatment #management ... #HIVAIDS #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Active TB: • HIV ... • HIV: 2/3 pulmonary ... Treatment: Active ... TST or IGRA HIV ... : • HIV-infected
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Active TB: • HIV ... • HIV: 2/3 pulmonary ... Treatment: Active ... TST or IGRA HIV ... : • HIV-infected
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Simplex Virus (HSV ... HIV-AIDS Treating ... Mucocutaneous HSV ... #IDSA #Prevention ... #HIVAIDS #pharmacology